Publications by authors named "Bertolo Frederic"

Claim this Profile
D
Dual inhibition of BET and EP300 has antitumor activity in undifferentiated pleomorphic sarcomas and synergizes with ferroptosis induction.
Stéphanie Verbeke, Aurélien Bourdon, Mathilde Lafon, Vanessa Chaire, Bertolo Frederic

Transl Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of pre-treatment computational radiomics, deep radiomics, and transcriptomics enhances soft-tissue sarcoma patient prognosis.
Amandine Crombé, Carlo Lucchesi, Frédéric Bertolo, Michèle Kind, Mariella Spalato-Ceruso

NPJ Precis Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering the correlation between metabolic activity through 18F-FDG-PET/CT and immune landscape in soft-tissue sarcomas: an insight from the NEOSARCOMICS study.
Amandine Crombé, Frédéric Bertolo, Lucile Vanhersecke, Jean-Philippe Guegan, Alban Bessede

Biomark Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct patterns of the natural evolution of soft tissue sarcomas on pre-treatment MRIs captured with delta-radiomics correlate with gene expression profiles.
Amandine Crombé, Frédéric Bertolo, David Fadli, Michèle Kind, François Le Loarer

Eur Radiol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies.
Maud Toulmonde, Carlo Lucchesi, Stéphanie Verbeke, Amandine Crombe, Julien Adam, Frederic Bertolo

EBioMedicine· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis